Sharif Tabebordbar On Raising $51 Million With His Team To Transform Pain Into Hope For Muscle Wasting Diseases
In a recent interview with Sharif Tabebordbar, co-founder of Kate Therapeutics, we delved into his personal journey, scientific endeavors, and the establishment of a groundbreaking company focused on developing gene therapies for genetic muscle diseases. The post Sharif Tabebordbar On Raising $51 Million With His Team To Transform Pain Into Hope For Muscle Wasting Diseases appeared first on Alejandro Cremades.